Biopharmaceutical characterisation studies 

RSSL can provide early characterisation of a wide range of compounds, therapeutic modalities and reference standards in respect of their potency, purity and physical properties.

 

To support you in the early phases of drug development, RSSL offers a comprehensive range of analytical techniques including our biopharmaceutical analysis to generate phase-appropriate methods to characterise your compound of interest. Our expert teams work across our labs to deliver these methods in accordance with ICH Q6B and EMA guidelines. 

 

Our services apply to monoclonal antibodies, antibody fragments, fusion proteins, conjugated proteins, intact RNA, viral vectors and lipid nanoparticles. 

 

Our broad extensive analytical techniques range from simple biopharmaceutical testing, such as pH and appearance, to mass spectrometry and capillary electrophoresis, as well as bespoke potency and functional assays, including bioassays. We also support with method development, transfer and validation. 

BMA R2 5950 HR Istock 499694183 Gettyimages 1023147086
For protein therapeutics, our characterisation studies include: 

Contact us

Need to get in touch? Either complete the enquiry form or call us:

Switchboard: +44 (0)118 918 4000

Customer Services: +44 (0)118 918 4076

We value your trust when sharing your personal data with us. We always treat your data in a fair and respectful manner limited to the purpose above mentioned. If you would like to know more about how we handle your data, please read our privacy notice.

;